124 related articles for article (PubMed ID: 3503100)
1. Ocular penetration and hypotensive activity of the topically applied carbonic anhydrase inhibitor L-645,151.
Bar-Ilan A; Pessah NI; Maren TH
J Ocul Pharmacol; 1986; 2(2):109-20. PubMed ID: 3503100
[TBL] [Abstract][Full Text] [Related]
2. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor.
Sharir M; Pierce WM; Chen D; Zimmerman TJ
Exp Eye Res; 1994 Jan; 58(1):107-16. PubMed ID: 8157096
[TBL] [Abstract][Full Text] [Related]
4. On the pharmacology of L-645,151: a topically effective ocular hypotensive carbonic anhydrase inhibitor.
Sugrue MF; Gautheron P; Schmitt C; Viader MP; Conquet P; Smith RL; Share NN; Stone CA
J Pharmacol Exp Ther; 1985 Feb; 232(2):534-40. PubMed ID: 3838190
[TBL] [Abstract][Full Text] [Related]
5. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
Brechue WF; Maren TH
Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
[TBL] [Abstract][Full Text] [Related]
6. Ocular disposition of aminozolamide in the rabbit eye.
Putnam ML; Schoenwald RD; Duffel MW; Barfknecht CF; Segarra TM; Campbell DA
Invest Ophthalmol Vis Sci; 1987 Aug; 28(8):1373-82. PubMed ID: 3610554
[TBL] [Abstract][Full Text] [Related]
7. Ocular distribution studies of the topical carbonic anhydrase inhibitors L-643,799 and L-650,719 and related alkyl prodrugs.
Grove J; Gautheron P; Plazonnet B; Sugrue MF
J Ocul Pharmacol; 1988; 4(4):279-90. PubMed ID: 3246565
[TBL] [Abstract][Full Text] [Related]
8. The transcorneal permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretion.
Maren TH; Jankowska L; Sanyal G; Edelhauser HF
Exp Eye Res; 1983 Apr; 36(4):457-79. PubMed ID: 6852128
[TBL] [Abstract][Full Text] [Related]
9. A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals.
Sugrue MF; Mallorga P; Schwam H; Baldwin JJ; Ponticello GS
Curr Eye Res; 1990 Jun; 9(6):607-15. PubMed ID: 2117519
[TBL] [Abstract][Full Text] [Related]
10. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Schwam H; Baldwin JJ; Christy ME; Ponticello GS
J Ocul Pharmacol; 1990; 6(1):9-22. PubMed ID: 2362161
[TBL] [Abstract][Full Text] [Related]
11. The effects of carbonic anhydrase inhibitors on aqueous humor chemistry and dynamics.
Bar-Ilan A; Pessah NI; Maren TH
Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1198-205. PubMed ID: 6434487
[TBL] [Abstract][Full Text] [Related]
12. Ocular hypotensive activity and disposition of the topical carbonic anhydrase inhibitor 6-hydroxy-benzo[b]thiophene-2-sulfonamide, L-650,719, in the rabbit.
Bar-Ilan A; Pessah NI; Maren TH
J Ocul Pharmacol; 1989; 5(2):99-110. PubMed ID: 2754300
[TBL] [Abstract][Full Text] [Related]
13. Preclinical overview of brinzolamide.
DeSantis L
Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S119-29. PubMed ID: 10665514
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
J Med Chem; 1999 Jul; 42(14):2641-50. PubMed ID: 10411484
[TBL] [Abstract][Full Text] [Related]
15. pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors.
Brechue WF; Maren TH
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2581-7. PubMed ID: 8325759
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in oclular normotensive and alpha-chymotrypsin-induced ocular hypertensive rabbits.
Puras G; Santafé J; Segarra J; Garrido M; Melena J
Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1559-67. PubMed ID: 17505840
[TBL] [Abstract][Full Text] [Related]
17. Effect of pH on the ocular distribution of a topical carbonic anhydrase inhibitor.
Conroy CW; Maren TH
Exp Eye Res; 1995 Aug; 61(2):213-22. PubMed ID: 7556485
[TBL] [Abstract][Full Text] [Related]
18. Fluorophotometric study of intravenous carbonic anhydrase inhibitors in rabbits.
Yablonski ME; Hayashi M; Cook DJ; Chubak G; Sirota M
Invest Ophthalmol Vis Sci; 1987 Dec; 28(12):2076-82. PubMed ID: 3679755
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring?
Borras J; Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
Bioorg Med Chem; 1999 Nov; 7(11):2397-406. PubMed ID: 10632049
[TBL] [Abstract][Full Text] [Related]
20. Topically active carbonic anhydrase inhibitors. 1. O-acyl derivatives of 6-hydroxybenzothiazole-2-sulfonamide.
Woltersdorf OW; Schwam H; Bicking JB; Brown SL; deSolms SJ; Fishman DR; Graham SL; Gautheron PD; Hoffman JM; Larson RD
J Med Chem; 1989 Nov; 32(11):2486-92. PubMed ID: 2810337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
